LANTHIOPEP B.V.
7Patents
7Active
7Granted
43Portfolio score
Filing activity: Dec 7, 2005 → Jun 8, 2017 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9290540B2 | Angiotensin Type 2 (AT2) receptor agonists and uses thereof | Human Necessities | 5 | Active |
| US9651558B2 | Bacterial surface display and screening of thioether-bridge-containing peptides | Chemistry; Metallurgy | 0 | Active |
| US10214563B2 | Angiotensin type 2 (AT2) receptor agonists and uses thereof | Human Necessities | 0 | Active |
| US9707268B2 | Angiotensin type 2 (AT2) receptor agonists and uses thereof | Human Necessities | 0 | Active |
| US10774323B2 | Methods for displaying cyclic peptides on bacteriophage particles | Chemistry; Metallurgy | 0 | Active |
| US8835616B2 | Methods for the production and secretion of modified peptides | Chemistry; Metallurgy | 0 | Active |
| US10501514B2 | Cyclic galanin-analogs and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.